Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
2.170
-0.080 (-3.56%)
At close: Dec 9, 2025, 4:00 PM EST
2.294
+0.124 (5.73%)
After-hours: Dec 9, 2025, 7:53 PM EST
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $8.25 million as of December 9, 2025. Its market cap has increased by 41.79% in one year.
Market Cap
8.25M
Enterprise Value
2.63M
1-Year Change
41.79%
Ranking
Category
Stock Price
$2.17
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $8.25M, a decrease of -99.28%. That is a compound annual growth rate of -66.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 8.25M | 30.90% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | 1.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 879.46B |
| Johnson & Johnson | 481.76B |
| AbbVie | 394.11B |
| UnitedHealth Group | 293.13B |
| AstraZeneca | 280.62B |
| Novartis AG | 254.28B |
| Merck & Co. | 240.48B |
| Thermo Fisher Scientific | 211.55B |